Article

RAS pathway activation drives clonal selection and monocytic differentiation in FLT3 and…

medRxiv · 2025 · Kennedy, V. E.; Peretz, C. A. C.; Walia, A.; Chyla, B.; Sun, Y.; Hill, J.; Tran, E.; Koh, A.; Ferng, T.; Pintar, S.; Jones, M.; Popescu, B.; Murad, N.; Roy, R.; Olshen, A.; Joshi, S.; Traer, E.; Dail, M.; Hamidi, H.; Altman, J.; Daver, N.; Levis, M.; McCloskey, J.; Perl, A.; Smith, C. C.

Key facts

Title RAS pathway activation drives clonal selection and monocytic differentiation in FLT3 and BCL2 inhibitor resistance
First author Kennedy, V. E.; Peretz, C. A. C.; Walia, A.; Chyla, B.; Sun, Y.; Hill, J.; Tran, E.; Koh, A.; Ferng, T.; Pintar, S.; Jones, M.; Popescu, B.; Murad, N.; Roy, R.; Olshen, A.; Joshi, S.; Traer, E.; Dail, M.; Hamidi, H.; Altman, J.; Daver, N.; Levis, M.; McCloskey, J.; Perl, A.; Smith, C. C.
Journal medRxiv
Published Jan 1, 2025
DOI 10.1101/2025.02.02.636108
Devices mentioned BK110039, DEN000008, K022086, K030408, K103302, K123955
Product codes mentioned GGL, GKZ, JCI, JJH, KIT, MVU, NDS, NJT, OOI, PFF, PFT, PCA

At a glance

  • 1–9 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature